alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
No. 10-1211.

#### Panagis Vartelas, Petitioner v. Eric H. Holder, Jr., Attorney General.

565 U.S. 972, 132 S. Ct. 475,

181 L. Ed. 2d 310,

2011 U.S. LEXIS 7598.

October 28, 2011.

Motion of petitioner to dispense with printing the joint appendix granted.
No. 10-10544.

#### Steven Mason, Petitioner v. New York.

565 U.S. 963, 132 S. Ct. 452,

181 L. Ed. 2d 294,

2011 U.S. LEXIS 7461.

October 17, 2011.

Petition for writ of certiorari to the Court of Appeals of New York denied.

Same case below, 16 N.Y.3d 145, 920 N.Y.S.2d 254, 945 N.E.2d 447.
<page>


EXHIBIT 32.01

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report of Morgan Stanley Charter
Graham L.P. (the ?Partnership?) on Form 10-Q for the period ended
June 30, 2006 as filed with the Securities and Exchange Commission
on the date hereof (the ?Report?), I, Walter Davis, President,
Demeter Management Corporation, the general partner of the
Partnership, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of my knowledge:
(1)	The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.









By:   /s/ Walter Davis

Name:		Walter Davis
Title:	President

Date:		August 14, 2006
April 2020 Events 

Enterprise-wide: 

Due to the current COVID -19 crisis all planned SAAPM events and activities have been 

"postponed" to ensure we are adhering to social distancing guidance.
No. 11-6044.

#### Jose Fernando Colon, Petitioner v. Fred Burnett, Warden, et al.

565 U.S. 982, 132 S. Ct. 506,

181 L. Ed. 2d 357,

2011 U.S. LEXIS 7894.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
No. 10-10976.

#### Joel Christopher Holmes, Petitioner v. Washington.

565 U.S. 860, 132 S. Ct. 197,

181 L. Ed. 2d 103,

2011 U.S. LEXIS 5967.

October 3, 2011.

Petition for writ of certiorari to the Court of Appeals of Washington, Division 1, denied.
##### 



EXHIBIT 31.2

CERTIFICATION

I, Timothy M. Mayleben, Chief Financial Officer of Esperion Therapeutics, Inc.,
certify that:

1. I have reviewed this quarterly report on Form 10-Q of Esperion
Therapeutics, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15 (e) and 15d-15 (e)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this quarterly report
is being prepared;

b) evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of
the end of the period covered by this quarterly report based upon such
evaluation; and

c) disclosed in this quarterly report any change in the registrants
internal control over financial reporting that occurred during the
registrants most recent fiscal quarter that has materially affected, or
is reasonably likely to materially affect, the registrants internal
control over financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of registrants board of
directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal
control over financial reporting.

/s/ Timothy M. Mayleben
Timothy M. Mayleben,
Chief Financial Officer

Date: November 10, 2003
DLA Troop Support 

2022 Hall of Fame Inductee 

PATRICIA PANZERA 

Ms. Patricia Panzera is being inducted into the Defense Logistics Agency Troop Support Hall of 

Fame, Class of 2022 for her outstanding mission support from 1981 to 2012. Ms. Panzera was 

an innovative leader of customer relations and process management who dedicated 31 years of 

federal service to DLA Troop Support.

Ms. Panzera’s exceptional acquisition knowledge and leadership skills ensured the men and 

women serving in the U.S. military experienced superior logistics support, benefited from 

millions of dollars in cost savings, and most importantly received outstanding customer service. 

Culminating her career as the Director of the Medical supply chain’s Supplier Operations, Ms. 

Panzera helped provide $4.6 billion of medical supplies and equipment to America’s warfighters 

and other DLA customers worldwide. She was responsible for facilitating the multi-year, multibillion-dollar, long-term Medical Prime Vendor contracts through the complex and demanding 

federal acquisition process, exceeding all expectations of thoroughness, and meeting every 

contractual and legal requirement. 

A role model for her staff and peers, Ms. Panzera was a visionary leader who built consensus, 

and demonstrated a commitment to excellence. Employees, supervisors, and other managers 

always sought the benefit of her extensive acquisition knowledge, and was a well-respected 

mentor.. Ms. Panzera was known for taking a personal interest in her employees’ well-being, 

and instilling confidence in them to consistently raise their respective bars of performance and 

prepare them for future leadership positions. 

Ms. Panzera’s extraordinary achievements throughout her illustrious career continues to benefit 

DLA customers today in the form of substantially lowered costs with dramatic increases in 

customer support and readiness posture. Her attention to detail and substantial knowledge of 

acquisition policies and procedures were evident in her daily work, and her willingness to share 

that knowledge with others continues to pay dividends for the entire DLA Troop Support 

organization.
\i' @o

rr) @o

cf) d

\o

rf)

\o@d

il

o

(.) o

(/)ooo

tL

.!a

t--

(b

b0

t\

\

r\)

\r\

'\\

-t"\ \N

ts

\)t\s6J 0

^d

.E og 3 ?iJ 'c)

glurs

E E E -.9

H gE EG g. 

=E 

>b A '- - s Eg 8r

a 

=6 

ED Er L. 

P'\ ar 

i E' _-.3 ; 6t rE = F 

:1q 

". 

tr Hv rr H rE Yc{ € d.E !tr 6

=- = =, 

F ;.

: U :5 E 

== E- tr = = 

El PE

= 

O EE 

= 

ui=

ur !, qE lL Li

E E Ei .e di, E rtr E,3 

'6 'c'*,,

3 E E 3 O 

"o-c ; 

=-3 

6 -i's--

E ; tr) \- 

(o(L

'g\ 

E p 

-. -,)

= 

.y B .i ;:3 a 'f - 

J (I)'

A . J

E' 

Ea .5 o--

"tr E: F(t,

- 

ar* - 

F E 5fr 9b tr, 9, a'

5 gE e.o E,: 

(oC E ,?- 

=.- E P Ol

, Ffrt rlao '=

Lt 

:f(t,

o.=

t-

(,F

TR

A)

t-)

rj

...9

afra

N9'

Til

6.)

)r

LI

r;lA

)trf 

r

pH

:r

F)

:.-r

I-

;c

-t

-)

-.

)-

Ai ps

A)

Q

rra

c

'dP

11

u-

;d

L}

.t

5a

iil H

A) I

><

A)

L}

{-. E

A} R3

A}

L.)

:a

ffi
Bob Rogers, Manager 

Pollution Control 

Shelby County Health Department 

814 Jefferson Ave. 

Memphis Tennessee 38105 

Dear Mr. Rogers: 

Thank you for your January 30,2014, email, concerning a prehearing package regarding the revisions to 

the Shelby County 1997 8-hour Ozone Maintenance Plan Update. This prehearing package is the subject 

of public hearings scheduled for March 4, 2014, and March 6, 2014, with written comments due by the 

close of business on March 14, 2014. We have completed a preliminary review of the submittal and 

offer the comments provided in the enclosed document. 

We look forward to continuing to work with you and your staff. If you have any questions, please 

contact Ms. Lynorae Benjamin, Chief, Regulatory Development Section at (404) 562-9040, or have your 

staff contact Mr. Sean Lakeman at (404) 562-9043. 

Enclosure 

Sincerely, 

R. Scott Davis 

Chief 

Air Planning Branch 

Internet Address {URL) • http://www.epa.gov 

Recyled/Recyclable • Printed with Vegetable Oil Based Inks on Recycled Paper (Minimum 30% Postconsum er) 
Key Comment 

1. Phase 3 of the Contingency Plan: For clarity, please specify that the regulatory programs that will be 

implemented to correct a monitored violation will be adopted and implemented within eighteen to 

twenty-four months of the trigger. 

General Comments 

2. On page 9-11 the Motor Vehicle Emissions Budget (MVEB) Section: In Table ill Shelby County has 

provided a great deal of detail on how the base year inventories with the safety margins have been 

prepared for Volatile Organic Compounds (VOC) and Nitrogen Oxides (NOx). However, this may be 

confusing to the general public. The EPA suggests that a Table IV be created to reflect MVEBs for years 

2006 and 2021. See below example: 

2006 and 2021 VOC and NOx Motor Vehicle Emission Budgets 

Shelby County Nonattainment Area 

Year Pollutants MVEB (tons/day) 

2006 voc 24.167 

NOx 58.013 

2021 voc 12.954 

NOx 56.428 

3. Please include a discussion on the methodology (MOVES2010b) used to calculate the mobile source 

emissions. The discussion can be included in attachments ill through VI. A discussion on Temperatures, 

Reid Vapor Pressure, and Humidity used as inputs will be helpful. Also a statement on how these 

planning assumptions were agreed on by interagency consultation should be included. 

4. On page 6 it clearly describes the attainment status for Particulate Matter. Doing the same for Lead, 

Nitrogen Dioxide and Sulfur Dioxide would enhance the non-interference showing. 

5. When submitting the final plan, please ensure the MOVES input/output files are included in the submission. An electronic copy on CD may be substituted for a hard copy (input/output files only). 

Please ensure the files are unzipped and in excel format. 

6. On page 3 the second paragraph under section 5 Emissions Reduction Requirements, please clarify 

the current ozone nonattainment status is for the 2008 8-hour ozone standard.
No. 11-5746.

#### Chevalier Riley Paige, Petitioner v. Rick Thaler, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

565 U.S. 950, 132 S. Ct. 413,

181 L. Ed. 2d 270,

2011 U.S. LEXIS 7387.

October 11, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
**Exhibit
      32.2**













**CERTIFICATION
      PURSUANT TO**






**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**










In
      connection with the Quarterly Report of American Community Properties Trust
      (the
“Company”) on Form 10-Q for the period ending March 31, 2007, as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Cynthia
      L. Hedrick, Chief Financial Officer of the Company, certify to my knowledge,
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section
      1350), that:








|1. | The
              Report fully complies with the requirements of Section 13(a) or 15(d)
              of
              the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. | The
              information contained in the Report fairly presents, in all material
              respects, the financial condition and results of operations of the
              Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------













/s/
                Cynthia L. HedrickCynthia
                L. HedrickChief
                Financial OfficerMay
                15, 2007
# 13 months
Exhibit 10.32


 


KINEMED, INC.


 


Non-Employee
Director Compensation Policy


 


Each non-employee director serving on the
Board of Directors (the “Board”) of KineMed, Inc. (the “Company”) will receive an annual
base fee for his or her services of $35,000, and a one-time initial award of options to purchase 16,666 shares of the Company’s
common stock, which will vest quarterly over a three-year period, subject to the director’s continued service on the Board.
Thereafter, each director will receive an annual award of options to purchase 6,666 shares of the Company’s common stock,
which will vest upon the earlier to occur of the one-year anniversary of the date of grant and the stockholder meeting in the year
following the date of grant, subject to the director’s continued service on the Board. The vice chairperson of the Board
will also receive an annual cash retainer of $20,000 for his or her service in such role. In addition, each non-employee director,
other than the chairperson of such committee, who serves on the audit, compensation, and nominating and corporate governance committees
will receive an annual cash retainer of $7,500, $5,000, and $5,000, respectively, for each committee on which he or she serves.
Each chairperson of the audit, compensation, and nominating and corporate governance committees will receive an additional annual
cash retainer of $15,000, $10,000 and $8,000, respectively. The Company will also reimburse each of the directors for their travel
expenses incurred in connection with their attendance at Board and committee meetings. All cash retainers will be paid in equal
quarterly installments.


 


Approved: 


Effective:
ACCEPTED

01-14-00693-CV

FIRST COURT OF APPEALS

HOUSTON, TEXAS

7/7/2015 8:10:16 PM

CHRISTOPHER PRINE

CLERK

 FILED IN 1st COURT OF APPEALS HOUSTON, TEXAS 7/7/2015 8:10:16 PM CHRISTOPHER A. PRINE Clerk
No. 11-5061.

#### In re Allah, Petitioner.

565 U.S. 812, 132 S. Ct. 391,

181 L. Ed. 2d 246,

2011 U.S. LEXIS 6537.

October 3, 2011.

Petition for writ of habeas corpus denied.
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 22-0544

STATE OF MONTANA,

Plaintiff and Appellee,

v.

JUSTIN JAMES SWANSON,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including January 30, 2023, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

December 23 2022

12/23/2022

Case Number: DA 22-0544
DLA FORM 1848, OCT 2011 PDF (DLA)

CHILD INJURY LOG

Page of 

PROGRAM/CENTER NAME CLASSROOM

Use This Button to Add, Insert, Move, or Delete Injury Log Entries for this Classroom

NAME OF CHILD:

DATE/TIME OF INJURY:

LOCATION:

WHO NOTIFIED PARENT?

PARENT NOTIFIED WHEN?

PARENT NOTIFIED HOW?

DESCRIPTION OF INCIDENT ACTION TAKEN

NAME OF PERSON COMPLETING REPORT & NAMES OF WITNESSES
<TABLE> <S> <C>

<ARTICLE>           5
<LEGEND>
This schedule contains summary financial information extracted from SEC
Form 10-K for the year ended November 1, 1997 and is qualified in its
entirety by reference to such statements.
</LEGEND>
<MULTIPLIER>        1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          NOV-01-1997
<PERIOD-END>                               NOV-01-1997
<CASH>                                          16,294
<SECURITIES>                                         0
<RECEIVABLES>                                   18,625
<ALLOWANCES>                                       337
<INVENTORY>                                     22,687
<CURRENT-ASSETS>                                61,338
<PP&E>                                          41,438
<DEPRECIATION>                                  16,227
<TOTAL-ASSETS>                                  99,357
<CURRENT-LIABILITIES>                           22,647
<BONDS>                                              0
<COMMON>                                           198
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      73,066
<TOTAL-LIABILITY-AND-EQUITY>                    99,357
<SALES>                                        113,010
<TOTAL-REVENUES>                               113,010
<CGS>                                           79,507
<TOTAL-COSTS>                                   83,207
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (139)
<INCOME-PRETAX>                                  7,945
<INCOME-TAX>                                     3,019
<INCOME-CONTINUING>                              4,926
<DISCONTINUED>                                     938
<EXTRAORDINARY>                                  6,770
<CHANGES>                                            0
<NET-INCOME>                                    12,634
<EPS-PRIMARY>                                     1.28
<EPS-DILUTED>                                     1.28
        

</TABLE>
No. 11-6508.

#### Dwight C. Jackson, Petitioner v. United States.

565 U.S. 990, 132 S. Ct. 529,

181 L. Ed. 2d 370,

2011 U.S. LEXIS 7706.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 429 Fed. Appx. 410.
No. 11-6595.

#### Syed Zaidi, Petitioner v. United States.

565 U.S. 992, 132 S. Ct. 535,

181 L. Ed. 2d 375,

2011 U.S. LEXIS 7655.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Exhibit 32.4

Written Statement of the Chief Financial Officer

Pursuant to 18 U.S.C. §1350

Solely for the purposes of complying with 18 U.S.C. §1350, I, the undersigned Chief Financial Officer of Regency Centers, L.P., hereby
certify, based on my knowledge, that the Quarterly Report on Form 10-Q of Regency Centers, L.P. for the quarter ended March 31, 2010(the Report) fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Regency Centers, L.P.

Date: May 6, 2010



|                                                                                     
|-------------------------------------------------------------------------------------
|/s/ Bruce M. Johnson                                                                 
|Bruce M. Johnson                                                                     
|Chief Financial Officer of Regency Centers Corporation, general partner of registrant
I 

116TH CONGRESS 

1ST SESSION H. R. 3224 

To amend title 38, United States Code, to provide for increased access 

to Department of Veterans Affairs medical care for women veterans. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 12, 2019 

Ms. BROWNLEY of California introduced the following bill; which was referred 

to the Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to provide for increased access to Department of Veterans Affairs medical care for women veterans. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. IMPROVED ACCESS TO DEPARTMENT OF VET4 ERANS AFFAIRS MEDICAL CARE FOR WOMEN 

5 VETERANS. 

6 (a) IN GENERAL.—Subchapter II of chapter 17 of 

7 title 38, United States Code, is amended by adding at the 

8 end the following new section: 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 3224 IH

1 ‘‘§ 1720J. Medical services for women veterans 

2 ‘‘(a) ACCESS TO CARE.—The Secretary shall ensure 

3 that gender specific services are continuously available at 

4 every medical center and community based outpatient clin5 ic of the Department. 

6 ‘‘(b) STUDY ON EXTENDED HOURS OF CARE.—The 

7 Secretary shall conduct a study to assess— 

8 ‘‘(1) the use of extended hours as a means of 

9 reducing barriers to care; 

10 ‘‘(2) the need for extended hours based on 

11 interviews with women veterans and employees; and 

12 ‘‘(3) the best practices and resources required 

13 to implement use of extended hours. 

14 ‘‘(c) ANNUAL REPORT TO CONGRESS.—Not later 

15 than September 30 of each year, the Secretary shall sub16 mit to the Committee on Veterans’ Affairs of the Senate 

17 and the Committee on Veterans’ Affairs of the House of 

18 Representatives a report on compliance with subsection 

19 (a).’’. 

20 (b) CLERICAL AMENDMENT.—The table of sections 

21 at the beginning of such chapter is amended by inserting 

22 after the item relating to section 1720I the following new 

23 item: 

‘‘1720J. Medical services for women veterans.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
**EXHIBIT
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of theglobe.com, inc. (the "Company")
      on
      Form 10-Q for the period ending September 30, 2007, as filed with the Securities
      and Exchange Commission on the date hereof (the "Report"), I, Michael S. Egan,
      Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section
      1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
      that
      to the best of my knowledge and belief:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




*Date:
                November 14, 2007*
            By:
            /s/*Michael
                S. Egan**Michael
                S. Egan**Chief
                Executive Officer*